129 related articles for article (PubMed ID: 16791958)
1. 13th Conference on Retrovirus and Opportunistic Infections. Metabolics and HIV. Update from the 13th CROI.
Berry J
Posit Aware; 2006; 17(3):22. PubMed ID: 16791958
[No Abstract] [Full Text] [Related]
2. 13th Conference on Retrovirus and Opportunistic Infections. Update on experimental HIV drugs. The newest, latest pipeline drugs from CROI.
Sharp M
Posit Aware; 2006; 17(3):17-9. PubMed ID: 16791956
[No Abstract] [Full Text] [Related]
3. Fish oil for treatment of hypertriglyceridemia in HIV infection: fish or foul?
Grunfeld C
Clin Infect Dis; 2005 Nov; 41(10):1505-6. PubMed ID: 16231264
[No Abstract] [Full Text] [Related]
4. Exploratory study: evaluating the effects of fish oil and controlled diet to reduce triglyceride levels in HIV.
Capili B; Anastasi JK
J Assoc Nurses AIDS Care; 2013; 24(3):276-82. PubMed ID: 22959481
[No Abstract] [Full Text] [Related]
5. 13th Conference on Retroviruses and Opportunistic Infections (CROI), Denver, USA, 5-8 February 2005.
Rusconi S
J HIV Ther; 2006 Mar; 11(1):20-2. PubMed ID: 16706252
[No Abstract] [Full Text] [Related]
6. Report from the 13th Conference on Retroviruses and Opportunistic Infections (CROI), February 5-8, 2006, Denver, Colorado.
TreatmentUpdate; 2006; 18(2):4-6. PubMed ID: 17230629
[No Abstract] [Full Text] [Related]
7. 14th annual retrovirus conference (CROI). New drugs at CROI: the four musketeers. New drugs new targets, new hope.
Berry J
Posit Aware; 2007; 18(3):21-3. PubMed ID: 17526109
[No Abstract] [Full Text] [Related]
8. Polyunsaturated ethyl esters of n-3 fatty acids in HIV-infected patients with moderate hypertriglyceridemia: comparison with dietary and lifestyle changes, and fibrate therapy.
Manfredi R; Calza L; Chiodo F
J Acquir Immune Defic Syndr; 2004 Jul; 36(3):878-80. PubMed ID: 15213574
[No Abstract] [Full Text] [Related]
9. Lamivudine monotherapy in an HIV-infected patient with the M184V mutation.
Chan-Tack KM; Edozien A
J Int Assoc Physicians AIDS Care (Chic); 2006 Sep; 5(3):121-2. PubMed ID: 16928882
[No Abstract] [Full Text] [Related]
10. Report from the 13th retrovirus conference. Antiretroviral therapy in resource-limited settings.
Friedland GH
AIDS Clin Care; 2006 Apr; 18(4):38. PubMed ID: 16718883
[No Abstract] [Full Text] [Related]
11. Update on the 9th Conference on Retroviruses and Opportunistic Infections.
Clifton CE
Posit Aware; 2002; 13(4):23-5. PubMed ID: 12171036
[No Abstract] [Full Text] [Related]
12. 14th annual retrovirus conference (CROI). One-on-one with Joseph J. Eron, MD. Interview by Jeff Berry.
Eron JJ
Posit Aware; 2007; 18(3):31-3. PubMed ID: 17526114
[No Abstract] [Full Text] [Related]
13. Report from Boston: the 12th Conference on Retroviruses and Opportunistic Infections (CROI). Complications/toxicity of HIV therapy.
Moore RD; Confrancesco J
Hopkins HIV Rep; 2005 May; 17(3):1-5, 9. PubMed ID: 16419310
[No Abstract] [Full Text] [Related]
14. 12th Conference on Retroviruses and Opportunistic Infections (CROI).
HIV Clin Trials; 2005; 6(3):169-81. PubMed ID: 16192250
[No Abstract] [Full Text] [Related]
15. Update from CROI 2008 on HIV-related infections and conditions.
McCord A
Proj Inf Perspect; 2008 Apr; (45):17-24. PubMed ID: 19248294
[No Abstract] [Full Text] [Related]
16. Summaries from the retrovirus conference, Part II.
Dunable D
Surviv News (Atlanta Ga); 2002 May; ():14-5. PubMed ID: 12085798
[No Abstract] [Full Text] [Related]
17. Shooting at a moving target: natural history studies and the rapidly improving state of anti-HIV treatment.
McKinney RE
J Pediatr; 2002 Sep; 141(3):301-2. PubMed ID: 12219046
[No Abstract] [Full Text] [Related]
18. Antiretroviral toxicities take center stage at the 9th CROI (Conference on Retroviruses and Opportunistic Infections).
Lucas GM
Hopkins HIV Rep; 2002 Mar; 14(2):1, 4, 9. PubMed ID: 12030207
[No Abstract] [Full Text] [Related]
19. Selected highlights from the 6th Conference on Retroviruses and Opportunistic Infections.
Bartnof HS
BETA; 1999 Apr; 12(2):33-52. PubMed ID: 11366695
[TBL] [Abstract][Full Text] [Related]
20. Special coverage: Retroviruses Conference 2006. Treatment interruption continues to be controversial strategy in HIV care. CROI studies show mixed results.
AIDS Alert; 2006 Mar; 21(3):13-6. PubMed ID: 17378059
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
